nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Urethral disorder—Methotrexate—stomach cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Infection—Docetaxel—stomach cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Weight decreased—Doxorubicin—stomach cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Diarrhoea—Irinotecan—stomach cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Dry mouth—Capecitabine—stomach cancer	0.00141	0.00141	CcSEcCtD
Milnacipran—Shock—Docetaxel—stomach cancer	0.00141	0.00141	CcSEcCtD
Milnacipran—Nervous system disorder—Docetaxel—stomach cancer	0.0014	0.0014	CcSEcCtD
Milnacipran—Pruritus—Fluorouracil—stomach cancer	0.0014	0.0014	CcSEcCtD
Milnacipran—Thrombocytopenia—Docetaxel—stomach cancer	0.0014	0.0014	CcSEcCtD
Milnacipran—Tachycardia—Docetaxel—stomach cancer	0.0014	0.0014	CcSEcCtD
Milnacipran—Skin disorder—Docetaxel—stomach cancer	0.00139	0.00139	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00139	0.00139	CcSEcCtD
Milnacipran—Infection—Capecitabine—stomach cancer	0.00138	0.00138	CcSEcCtD
Milnacipran—Erythema multiforme—Methotrexate—stomach cancer	0.00137	0.00137	CcSEcCtD
Milnacipran—Dizziness—Irinotecan—stomach cancer	0.00137	0.00137	CcSEcCtD
Milnacipran—Anorexia—Docetaxel—stomach cancer	0.00136	0.00136	CcSEcCtD
Milnacipran—Shock—Capecitabine—stomach cancer	0.00136	0.00136	CcSEcCtD
Milnacipran—Urinary tract infection—Doxorubicin—stomach cancer	0.00136	0.00136	CcSEcCtD
Milnacipran—Nervous system disorder—Capecitabine—stomach cancer	0.00136	0.00136	CcSEcCtD
Milnacipran—Hepatitis—Epirubicin—stomach cancer	0.00136	0.00136	CcSEcCtD
Milnacipran—Eye disorder—Methotrexate—stomach cancer	0.00136	0.00136	CcSEcCtD
Milnacipran—Diarrhoea—Fluorouracil—stomach cancer	0.00136	0.00136	CcSEcCtD
Milnacipran—Thrombocytopenia—Capecitabine—stomach cancer	0.00136	0.00136	CcSEcCtD
Milnacipran—Tachycardia—Capecitabine—stomach cancer	0.00135	0.00135	CcSEcCtD
Milnacipran—Hypoaesthesia—Epirubicin—stomach cancer	0.00135	0.00135	CcSEcCtD
Milnacipran—Cardiac disorder—Methotrexate—stomach cancer	0.00135	0.00135	CcSEcCtD
Milnacipran—Skin disorder—Capecitabine—stomach cancer	0.00135	0.00135	CcSEcCtD
Milnacipran—Urinary tract disorder—Epirubicin—stomach cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Hyperhidrosis—Capecitabine—stomach cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Oedema peripheral—Epirubicin—stomach cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Hypotension—Docetaxel—stomach cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Haematuria—Doxorubicin—stomach cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Connective tissue disorder—Epirubicin—stomach cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Urethral disorder—Epirubicin—stomach cancer	0.00133	0.00133	CcSEcCtD
Milnacipran—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00133	0.00133	CcSEcCtD
Milnacipran—Anorexia—Capecitabine—stomach cancer	0.00132	0.00132	CcSEcCtD
Milnacipran—Angiopathy—Methotrexate—stomach cancer	0.00132	0.00132	CcSEcCtD
Milnacipran—Vomiting—Irinotecan—stomach cancer	0.00132	0.00132	CcSEcCtD
Milnacipran—Dizziness—Fluorouracil—stomach cancer	0.00131	0.00131	CcSEcCtD
Milnacipran—Mediastinal disorder—Methotrexate—stomach cancer	0.00131	0.00131	CcSEcCtD
Milnacipran—Rash—Irinotecan—stomach cancer	0.00131	0.00131	CcSEcCtD
Milnacipran—Dermatitis—Irinotecan—stomach cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Chills—Methotrexate—stomach cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Headache—Irinotecan—stomach cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Hypotension—Capecitabine—stomach cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Insomnia—Docetaxel—stomach cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Paraesthesia—Docetaxel—stomach cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Erythema multiforme—Epirubicin—stomach cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Dyspnoea—Docetaxel—stomach cancer	0.00128	0.00128	CcSEcCtD
Milnacipran—Somnolence—Docetaxel—stomach cancer	0.00127	0.00127	CcSEcCtD
Milnacipran—Mental disorder—Methotrexate—stomach cancer	0.00127	0.00127	CcSEcCtD
Milnacipran—Eye disorder—Epirubicin—stomach cancer	0.00127	0.00127	CcSEcCtD
Milnacipran—Malnutrition—Methotrexate—stomach cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Flushing—Epirubicin—stomach cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Cardiac disorder—Epirubicin—stomach cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Vomiting—Fluorouracil—stomach cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Dyspepsia—Docetaxel—stomach cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Hepatitis—Doxorubicin—stomach cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Insomnia—Capecitabine—stomach cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Hypoaesthesia—Doxorubicin—stomach cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Rash—Fluorouracil—stomach cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Dermatitis—Fluorouracil—stomach cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Paraesthesia—Capecitabine—stomach cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Decreased appetite—Docetaxel—stomach cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Headache—Fluorouracil—stomach cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Urinary tract disorder—Doxorubicin—stomach cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Oedema peripheral—Doxorubicin—stomach cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Dysgeusia—Methotrexate—stomach cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Connective tissue disorder—Doxorubicin—stomach cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Dyspnoea—Capecitabine—stomach cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Fatigue—Docetaxel—stomach cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Angiopathy—Epirubicin—stomach cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Urethral disorder—Doxorubicin—stomach cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Nausea—Irinotecan—stomach cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Mediastinal disorder—Epirubicin—stomach cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Constipation—Docetaxel—stomach cancer	0.00122	0.00122	CcSEcCtD
Milnacipran—Dyspepsia—Capecitabine—stomach cancer	0.00122	0.00122	CcSEcCtD
Milnacipran—Chills—Epirubicin—stomach cancer	0.00122	0.00122	CcSEcCtD
Milnacipran—Decreased appetite—Capecitabine—stomach cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Capecitabine—stomach cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Fatigue—Capecitabine—stomach cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Vision blurred—Methotrexate—stomach cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Mental disorder—Epirubicin—stomach cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Erythema multiforme—Doxorubicin—stomach cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Constipation—Capecitabine—stomach cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Malnutrition—Epirubicin—stomach cancer	0.00118	0.00118	CcSEcCtD
Milnacipran—Nausea—Fluorouracil—stomach cancer	0.00118	0.00118	CcSEcCtD
Milnacipran—Eye disorder—Doxorubicin—stomach cancer	0.00118	0.00118	CcSEcCtD
Milnacipran—Gastrointestinal pain—Docetaxel—stomach cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Cardiac disorder—Doxorubicin—stomach cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Flushing—Doxorubicin—stomach cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Flatulence—Epirubicin—stomach cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Tension—Epirubicin—stomach cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Dysgeusia—Epirubicin—stomach cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Angiopathy—Doxorubicin—stomach cancer	0.00114	0.00114	CcSEcCtD
Milnacipran—Gastrointestinal pain—Capecitabine—stomach cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Mediastinal disorder—Doxorubicin—stomach cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Abdominal pain—Docetaxel—stomach cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Body temperature increased—Docetaxel—stomach cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Leukopenia—Methotrexate—stomach cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Chills—Doxorubicin—stomach cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Vision blurred—Epirubicin—stomach cancer	0.00112	0.00112	CcSEcCtD
Milnacipran—Mental disorder—Doxorubicin—stomach cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Urticaria—Capecitabine—stomach cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Body temperature increased—Capecitabine—stomach cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Abdominal pain—Capecitabine—stomach cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Convulsion—Methotrexate—stomach cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Malnutrition—Doxorubicin—stomach cancer	0.00109	0.00109	CcSEcCtD
Milnacipran—Agitation—Epirubicin—stomach cancer	0.00109	0.00109	CcSEcCtD
Milnacipran—Flatulence—Doxorubicin—stomach cancer	0.00108	0.00108	CcSEcCtD
Milnacipran—Chest pain—Methotrexate—stomach cancer	0.00108	0.00108	CcSEcCtD
Milnacipran—Tension—Doxorubicin—stomach cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Dysgeusia—Doxorubicin—stomach cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Syncope—Epirubicin—stomach cancer	0.00106	0.00106	CcSEcCtD
Milnacipran—Leukopenia—Epirubicin—stomach cancer	0.00106	0.00106	CcSEcCtD
Milnacipran—Hypersensitivity—Docetaxel—stomach cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Palpitations—Epirubicin—stomach cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Loss of consciousness—Epirubicin—stomach cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Vision blurred—Doxorubicin—stomach cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Asthenia—Docetaxel—stomach cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Convulsion—Epirubicin—stomach cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Infection—Methotrexate—stomach cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Hypertension—Epirubicin—stomach cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Hypersensitivity—Capecitabine—stomach cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Pruritus—Docetaxel—stomach cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Nervous system disorder—Methotrexate—stomach cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Thrombocytopenia—Methotrexate—stomach cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Chest pain—Epirubicin—stomach cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Agitation—Doxorubicin—stomach cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Anxiety—Epirubicin—stomach cancer	0.001	0.001	CcSEcCtD
Milnacipran—Skin disorder—Methotrexate—stomach cancer	0.001	0.001	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.001	0.001	CcSEcCtD
Milnacipran—Hyperhidrosis—Methotrexate—stomach cancer	0.000998	0.000998	CcSEcCtD
Milnacipran—Asthenia—Capecitabine—stomach cancer	0.000995	0.000995	CcSEcCtD
Milnacipran—Dry mouth—Epirubicin—stomach cancer	0.000985	0.000985	CcSEcCtD
Milnacipran—Anorexia—Methotrexate—stomach cancer	0.000984	0.000984	CcSEcCtD
Milnacipran—Syncope—Doxorubicin—stomach cancer	0.000982	0.000982	CcSEcCtD
Milnacipran—Pruritus—Capecitabine—stomach cancer	0.000981	0.000981	CcSEcCtD
Milnacipran—Leukopenia—Doxorubicin—stomach cancer	0.00098	0.00098	CcSEcCtD
Milnacipran—Diarrhoea—Docetaxel—stomach cancer	0.00098	0.00098	CcSEcCtD
Milnacipran—Palpitations—Doxorubicin—stomach cancer	0.000968	0.000968	CcSEcCtD
Milnacipran—Hypotension—Methotrexate—stomach cancer	0.000964	0.000964	CcSEcCtD
Milnacipran—Loss of consciousness—Doxorubicin—stomach cancer	0.000962	0.000962	CcSEcCtD
Milnacipran—Infection—Epirubicin—stomach cancer	0.000959	0.000959	CcSEcCtD
Milnacipran—Shock—Epirubicin—stomach cancer	0.00095	0.00095	CcSEcCtD
Milnacipran—Convulsion—Doxorubicin—stomach cancer	0.000949	0.000949	CcSEcCtD
Milnacipran—Diarrhoea—Capecitabine—stomach cancer	0.000948	0.000948	CcSEcCtD
Milnacipran—Nervous system disorder—Epirubicin—stomach cancer	0.000947	0.000947	CcSEcCtD
Milnacipran—Dizziness—Docetaxel—stomach cancer	0.000947	0.000947	CcSEcCtD
Milnacipran—Thrombocytopenia—Epirubicin—stomach cancer	0.000946	0.000946	CcSEcCtD
Milnacipran—Hypertension—Doxorubicin—stomach cancer	0.000945	0.000945	CcSEcCtD
Milnacipran—Tachycardia—Epirubicin—stomach cancer	0.000943	0.000943	CcSEcCtD
Milnacipran—Skin disorder—Epirubicin—stomach cancer	0.000938	0.000938	CcSEcCtD
Milnacipran—Hyperhidrosis—Epirubicin—stomach cancer	0.000934	0.000934	CcSEcCtD
Milnacipran—Insomnia—Methotrexate—stomach cancer	0.000933	0.000933	CcSEcCtD
Milnacipran—Chest pain—Doxorubicin—stomach cancer	0.000932	0.000932	CcSEcCtD
Milnacipran—Anxiety—Doxorubicin—stomach cancer	0.000929	0.000929	CcSEcCtD
Milnacipran—Paraesthesia—Methotrexate—stomach cancer	0.000927	0.000927	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000926	0.000926	CcSEcCtD
Milnacipran—Anorexia—Epirubicin—stomach cancer	0.000921	0.000921	CcSEcCtD
Milnacipran—Dyspnoea—Methotrexate—stomach cancer	0.00092	0.00092	CcSEcCtD
Milnacipran—Somnolence—Methotrexate—stomach cancer	0.000917	0.000917	CcSEcCtD
Milnacipran—Dizziness—Capecitabine—stomach cancer	0.000917	0.000917	CcSEcCtD
Milnacipran—Dry mouth—Doxorubicin—stomach cancer	0.000912	0.000912	CcSEcCtD
Milnacipran—Vomiting—Docetaxel—stomach cancer	0.00091	0.00091	CcSEcCtD
Milnacipran—Dyspepsia—Methotrexate—stomach cancer	0.000908	0.000908	CcSEcCtD
Milnacipran—Rash—Docetaxel—stomach cancer	0.000903	0.000903	CcSEcCtD
Milnacipran—Hypotension—Epirubicin—stomach cancer	0.000902	0.000902	CcSEcCtD
Milnacipran—Dermatitis—Docetaxel—stomach cancer	0.000902	0.000902	CcSEcCtD
Milnacipran—Decreased appetite—Methotrexate—stomach cancer	0.000897	0.000897	CcSEcCtD
Milnacipran—Headache—Docetaxel—stomach cancer	0.000897	0.000897	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000891	0.000891	CcSEcCtD
Milnacipran—Fatigue—Methotrexate—stomach cancer	0.00089	0.00089	CcSEcCtD
Milnacipran—Infection—Doxorubicin—stomach cancer	0.000888	0.000888	CcSEcCtD
Milnacipran—Vomiting—Capecitabine—stomach cancer	0.000881	0.000881	CcSEcCtD
Milnacipran—Shock—Doxorubicin—stomach cancer	0.000879	0.000879	CcSEcCtD
Milnacipran—Nervous system disorder—Doxorubicin—stomach cancer	0.000876	0.000876	CcSEcCtD
Milnacipran—Thrombocytopenia—Doxorubicin—stomach cancer	0.000875	0.000875	CcSEcCtD
Milnacipran—Rash—Capecitabine—stomach cancer	0.000874	0.000874	CcSEcCtD
Milnacipran—Insomnia—Epirubicin—stomach cancer	0.000873	0.000873	CcSEcCtD
Milnacipran—Dermatitis—Capecitabine—stomach cancer	0.000873	0.000873	CcSEcCtD
Milnacipran—Tachycardia—Doxorubicin—stomach cancer	0.000872	0.000872	CcSEcCtD
Milnacipran—Headache—Capecitabine—stomach cancer	0.000868	0.000868	CcSEcCtD
Milnacipran—Skin disorder—Doxorubicin—stomach cancer	0.000868	0.000868	CcSEcCtD
Milnacipran—Paraesthesia—Epirubicin—stomach cancer	0.000867	0.000867	CcSEcCtD
Milnacipran—Hyperhidrosis—Doxorubicin—stomach cancer	0.000864	0.000864	CcSEcCtD
Milnacipran—Dyspnoea—Epirubicin—stomach cancer	0.000861	0.000861	CcSEcCtD
Milnacipran—Somnolence—Epirubicin—stomach cancer	0.000859	0.000859	CcSEcCtD
Milnacipran—Anorexia—Doxorubicin—stomach cancer	0.000852	0.000852	CcSEcCtD
Milnacipran—Nausea—Docetaxel—stomach cancer	0.00085	0.00085	CcSEcCtD
Milnacipran—Dyspepsia—Epirubicin—stomach cancer	0.00085	0.00085	CcSEcCtD
Milnacipran—Gastrointestinal pain—Methotrexate—stomach cancer	0.000844	0.000844	CcSEcCtD
Milnacipran—Decreased appetite—Epirubicin—stomach cancer	0.00084	0.00084	CcSEcCtD
Milnacipran—Hypotension—Doxorubicin—stomach cancer	0.000835	0.000835	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000834	0.000834	CcSEcCtD
Milnacipran—Fatigue—Epirubicin—stomach cancer	0.000833	0.000833	CcSEcCtD
Milnacipran—Constipation—Epirubicin—stomach cancer	0.000826	0.000826	CcSEcCtD
Milnacipran—Nausea—Capecitabine—stomach cancer	0.000823	0.000823	CcSEcCtD
Milnacipran—Urticaria—Methotrexate—stomach cancer	0.00082	0.00082	CcSEcCtD
Milnacipran—Abdominal pain—Methotrexate—stomach cancer	0.000816	0.000816	CcSEcCtD
Milnacipran—Body temperature increased—Methotrexate—stomach cancer	0.000816	0.000816	CcSEcCtD
Milnacipran—Insomnia—Doxorubicin—stomach cancer	0.000808	0.000808	CcSEcCtD
Milnacipran—Paraesthesia—Doxorubicin—stomach cancer	0.000802	0.000802	CcSEcCtD
Milnacipran—Dyspnoea—Doxorubicin—stomach cancer	0.000797	0.000797	CcSEcCtD
Milnacipran—Somnolence—Doxorubicin—stomach cancer	0.000794	0.000794	CcSEcCtD
Milnacipran—Gastrointestinal pain—Epirubicin—stomach cancer	0.00079	0.00079	CcSEcCtD
Milnacipran—Dyspepsia—Doxorubicin—stomach cancer	0.000787	0.000787	CcSEcCtD
Milnacipran—Decreased appetite—Doxorubicin—stomach cancer	0.000777	0.000777	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000771	0.000771	CcSEcCtD
Milnacipran—Fatigue—Doxorubicin—stomach cancer	0.00077	0.00077	CcSEcCtD
Milnacipran—Urticaria—Epirubicin—stomach cancer	0.000767	0.000767	CcSEcCtD
Milnacipran—Constipation—Doxorubicin—stomach cancer	0.000764	0.000764	CcSEcCtD
Milnacipran—Body temperature increased—Epirubicin—stomach cancer	0.000763	0.000763	CcSEcCtD
Milnacipran—Abdominal pain—Epirubicin—stomach cancer	0.000763	0.000763	CcSEcCtD
Milnacipran—Hypersensitivity—Methotrexate—stomach cancer	0.00076	0.00076	CcSEcCtD
Milnacipran—Asthenia—Methotrexate—stomach cancer	0.00074	0.00074	CcSEcCtD
Milnacipran—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000731	0.000731	CcSEcCtD
Milnacipran—Pruritus—Methotrexate—stomach cancer	0.00073	0.00073	CcSEcCtD
Milnacipran—Hypersensitivity—Epirubicin—stomach cancer	0.000712	0.000712	CcSEcCtD
Milnacipran—Urticaria—Doxorubicin—stomach cancer	0.00071	0.00071	CcSEcCtD
Milnacipran—Abdominal pain—Doxorubicin—stomach cancer	0.000706	0.000706	CcSEcCtD
Milnacipran—Body temperature increased—Doxorubicin—stomach cancer	0.000706	0.000706	CcSEcCtD
Milnacipran—Diarrhoea—Methotrexate—stomach cancer	0.000706	0.000706	CcSEcCtD
Milnacipran—Asthenia—Epirubicin—stomach cancer	0.000693	0.000693	CcSEcCtD
Milnacipran—Pruritus—Epirubicin—stomach cancer	0.000683	0.000683	CcSEcCtD
Milnacipran—Dizziness—Methotrexate—stomach cancer	0.000682	0.000682	CcSEcCtD
Milnacipran—Diarrhoea—Epirubicin—stomach cancer	0.000661	0.000661	CcSEcCtD
Milnacipran—Hypersensitivity—Doxorubicin—stomach cancer	0.000658	0.000658	CcSEcCtD
Milnacipran—Vomiting—Methotrexate—stomach cancer	0.000656	0.000656	CcSEcCtD
Milnacipran—Rash—Methotrexate—stomach cancer	0.000651	0.000651	CcSEcCtD
Milnacipran—Dermatitis—Methotrexate—stomach cancer	0.00065	0.00065	CcSEcCtD
Milnacipran—Headache—Methotrexate—stomach cancer	0.000646	0.000646	CcSEcCtD
Milnacipran—Asthenia—Doxorubicin—stomach cancer	0.000641	0.000641	CcSEcCtD
Milnacipran—Dizziness—Epirubicin—stomach cancer	0.000639	0.000639	CcSEcCtD
Milnacipran—Pruritus—Doxorubicin—stomach cancer	0.000632	0.000632	CcSEcCtD
Milnacipran—Vomiting—Epirubicin—stomach cancer	0.000614	0.000614	CcSEcCtD
Milnacipran—Nausea—Methotrexate—stomach cancer	0.000613	0.000613	CcSEcCtD
Milnacipran—Diarrhoea—Doxorubicin—stomach cancer	0.000611	0.000611	CcSEcCtD
Milnacipran—Rash—Epirubicin—stomach cancer	0.000609	0.000609	CcSEcCtD
Milnacipran—Dermatitis—Epirubicin—stomach cancer	0.000608	0.000608	CcSEcCtD
Milnacipran—Headache—Epirubicin—stomach cancer	0.000605	0.000605	CcSEcCtD
Milnacipran—Dizziness—Doxorubicin—stomach cancer	0.000591	0.000591	CcSEcCtD
Milnacipran—Nausea—Epirubicin—stomach cancer	0.000574	0.000574	CcSEcCtD
Milnacipran—Vomiting—Doxorubicin—stomach cancer	0.000568	0.000568	CcSEcCtD
Milnacipran—Rash—Doxorubicin—stomach cancer	0.000563	0.000563	CcSEcCtD
Milnacipran—Dermatitis—Doxorubicin—stomach cancer	0.000563	0.000563	CcSEcCtD
Milnacipran—Headache—Doxorubicin—stomach cancer	0.00056	0.00056	CcSEcCtD
Milnacipran—Nausea—Doxorubicin—stomach cancer	0.000531	0.000531	CcSEcCtD
